Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,062 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China.
Wang W, Zhang W, Su LP, Liu LH, Gao YH, Wang QS, Su H, Song YQ, Zhang HL, Shen J, Jing HM, Wang SY, Cen XN, Liu H, Liu AC, Li ZJ, Luo JM, He JX, Wang JW, O'Connor OA, Zhou DB. Wang W, et al. Among authors: wang jw, wang qs, wang sy. Ann Hematol. 2024 Aug;103(8):3061-3069. doi: 10.1007/s00277-024-05708-w. Epub 2024 May 28. Ann Hematol. 2024. PMID: 38805037 Clinical Trial.
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China.
Shi Y, Jia B, Xu W, Li W, Liu T, Liu P, Zhao W, Zhang H, Sun X, Yang H, Zhang X, Jin J, Jin Z, Li Z, Qiu L, Dong M, Huang X, Luo Y, Wang X, Wang X, Wu J, Xu J, Yi P, Zhou J, He H, Liu L, Shen J, Tang X, Wang J, Yang J, Zeng Q, Zhang Z, Cai Z, Chen X, Ding K, Hou M, Huang H, Li X, Liang R, Liu Q, Song Y, Su H, Gao Y, Liu L, Luo J, Su L, Sun Z, Tan H, Wang H, Wang J, Wang S, Zhang H, Zhang X, Zhou D, Bai O, Wu G, Zhang L, Zhang Y. Shi Y, et al. J Hematol Oncol. 2017 Mar 15;10(1):69. doi: 10.1186/s13045-017-0439-6. J Hematol Oncol. 2017. PMID: 28298231 Free PMC article.
The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study.
Zhang W, Su L, Liu L, Gao Y, Wang Q, Su H, Song Y, Zhang H, Shen J, Jing H, Wang S, Cen X, Liu H, Liu A, Li Z, Luo J, He J, Wang J, O'Connor OA, Zhou D. Zhang W, et al. Cancer Biol Med. 2021 Mar 23;18(3):841-8. doi: 10.20892/j.issn.2095-3941.2020.0413. Online ahead of print. Cancer Biol Med. 2021. PMID: 33755379 Free PMC article.
Real-world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis.
Yang P, Cai QQ, Zhang W, Liu SZ, Liu H, Sun XH, Dong YJ, Xiao XB, Wang JW, Li ZL, Huang WR, Li LH, Bao HZ, Yang W, Wang YL, Wang SY, He J, Li XL, Liu AC, Jing HM. Yang P, et al. Among authors: wang jw, wang yl, wang sy. Cancer Med. 2023 Jun;12(12):13204-13216. doi: 10.1002/cam4.6009. Epub 2023 May 6. Cancer Med. 2023. PMID: 37148540 Free PMC article.
Comparison of Clinical Efficacy of Cytarabine with Different Regimens in Postremission Consolidation Therapy for Adult t(8;21) AML Patients: A Multicenter Retrospective Study in China.
Gong D, Li W, Hu LD, Shen JL, Fang MY, Yang QM, Wang HX, Ke XY, Chen HR, Wang Z, Liu H, Liu F, Ma YG, Wang JW, Li HH, Wang QS, Jing Y, Gao XN, Dou LP, Li YH, Luo JM, Yu L. Gong D, et al. Among authors: wang jw, wang hx, wang z, wang qs. Acta Haematol. 2016;136(4):201-209. doi: 10.1159/000448209. Epub 2016 Sep 17. Acta Haematol. 2016. PMID: 27640088
Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure.
Hu S, Song Y, Sun X, Su L, Zhang W, Jia J, Bai O, Yang S, Liang R, Li X, Zhang H, Gao Y, Zhang W, Xiao X, Bao H, Wang N, Ren H, Cen X, Yang S, Zhao Y, Wang Y, Wang Y, Liu A, Wang J, Shi Y, Yuan M, Li Y, He X. Hu S, et al. Cancer Sci. 2018 Dec;109(12):3943-3952. doi: 10.1111/cas.13828. Epub 2018 Nov 11. Cancer Sci. 2018. PMID: 30302857 Free PMC article.
First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study.
Zhong K, Shi Y, Gao Y, Zhang H, Zhang M, Zhang Q, Cen X, Xue M, Qin Y, Zhao Y, Zhang L, Liang R, Wang N, Xie Y, Yang Y, Liu A, Bao H, Wang J, Cao B, Zhang W, Zhang W. Zhong K, et al. BMC Cancer. 2023 Aug 11;23(1):746. doi: 10.1186/s12885-023-11268-5. BMC Cancer. 2023. PMID: 37568079 Free PMC article.
[Clinical Features and Prognosis of t(8;21) AML Patients in China: A Multicenter Retrospective Study].
Gong D, Li W, Hu LD, Luo JM, Shen JL, Fang MY, Yang QM, Wang HX, Ke XY, Chen HR, Wang Z, Liu H, Liu F, Ma YG, Wang JW, Li HH, Wang QS, Jing Y, Gao XN, Dou LP, Li YH, Yu L. Gong D, et al. Among authors: wang jw, wang hx, wang z, wang qs. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Aug;25(4):980-986. doi: 10.7534/j.issn.1009-2137.2017.04.004. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 28823255 Chinese.
Antitumor activity and safety of camrelizumab combined with apatinib in patients with relapsed or refractory peripheral T-cell lymphoma: An open-label, multicenter, phase II study.
Liu Y, Song Y, Zuo S, Zhang X, Liu H, Wang J, Wang J, Tang Y, Zheng W, Ying Z, Ping L, Zhang C, Wu M, Zhu J, Xie Y. Liu Y, et al. Front Immunol. 2023 Apr 4;14:1128172. doi: 10.3389/fimmu.2023.1128172. eCollection 2023. Front Immunol. 2023. PMID: 37081867 Free PMC article. Clinical Trial.
2,062 results